-
Celonic to Become a Long-Term Partner of the Federal Republic of Germany for Vaccine Supply
b3cnewswire.com
March 28, 2022
The Federal Republic of Germany has announced its decision to sign contracts with Celonic AG and four other partners to secure the long-term supply of vaccines in Germany against Covid-19 and other pandemics...
-
Novavax files for Conditional Marketing Authorisation of COVID-19 vaccine in Switzerland
ExpressPharma
February 15, 2022
The submission for the regulatory evaluation of the vaccine includes data from two phase-III clinical trials.
-
Vaccine Effectiveness Up After Three COVID-19 Vaccine Doses
drugs.com
February 14, 2022
COVID-19 vaccine effectiveness (VE) is increased after three doses but wanes with time since vaccination after receipt of two or three...
-
AstraZeneca reports 41% growth in FY 2021 total revenue
Pharmaceutical-Technology
February 11, 2022
Total revenue for the Covid-19 sector was recorded at $4.11bn in FY 2021.
-
Mandatory COVID-19 Tests Lifted for Vaccinated Travelers to Britain
drugs.com
February 11, 2022
Vaccinated travelers will no longer have to take COVID-19 tests when they enter Britain, officials announced Friday.
-
Plant “biofactories” produce proteins for potential COVID-19 vaccine
EuropeanPharmaceuticalReview
February 10, 2022
COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 replicates by infecting human cells via the interaction of the receptor-binding domain (RBD) on the viral Spike (S) protein...
-
Some Canadian Provinces Lift COVID Restrictions Amid Ongoing Protests
drugs.com
February 10, 2022
Four Canadian provinces said this week that they'll lift their COVID-19 restrictions as the wave of cases caused by the Omicron variant has crested nationwide.
-
Seqirus Announces New Facility Supporting R&D of Leading-Edge Influenza Vaccine Technology
AmericanPharmaceuticalReview
February 09, 2022
Seqirus, a business of CSL Limited, announced an investment in a new Research and Development (R&D) facility located in Waltham, Mass. The new facility will support the company's growing R&D portfolio...
-
Moderna to supply 10.8 million Covid-19 vaccine doses to Colombia
Pharmaceutical-Technology
February 09, 2022
Initially, Moderna plans to supply one million doses of the vaccine in the first quarter of this year.
-
Sustainability vs single-use-tech: how COVID-19 has made biopharma more sustainable
CPhIonline
February 09, 2022
COVID-19 saw biopharma turn to single-use technology in a big way. But greater use of disposable manufacturing systems does not necessarily mean drug and vaccine production has become less environmentally sustainable.